NCT06454747 - Randomized Study Using SM-030 Gel for Adults With Melasma | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

June 27, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

October 31, 2025

Conditions

Melasma

Interventions

DRUG

SM-030 gel 0.64%

Topical application to face twice daily for 12 weeks.

DRUG

Placebo gel

Topical application to face twice daily for 12 weeks.

DRUG

SM-030 gel 0.08%

Topical application to face twice daily for 12 weeks.

Trial Locations (2)

RECRUITING

Zepeda Dermatologia, Santa Tecla

RECRUITING

Centro de Investigación y Desarrollo Brioso Ramirez, Santa Tecla, La Libertad, El Salvador